Insider transactions Cytokinetics, Incorporated

Stocks

CYTK

US23282W6057

Biotechnology & Medical Research

Market Closed - Nasdaq Other stock markets 21:00:00 13/07/2026 BST			5-day change	1st Jan Change
82.24 ^USD	-3.10%		-3.89%	+29.43%

07-07	RBC Capital Adjusts Cytokinetics Price Target to $117 From $119, Maintains Outperform Rating	MT
07-02	Cytokinetics Insider Sold Shares Worth $1,287,000, According to a Recent SEC Filing	MT

Insider Transaction History

Latest insider transactions for Cytokinetics, Incorporated

Date	Insider	Type	Main position	Quantity	Price	Amount	% Market Cap.
07-06	Fady Malik	Fiscal year	Chief Technology Officer	10,500	47.21	330K	0.0084%
06-30	Robert Blum	Sell	Chief Executive Officer	-7,500	84.92	-	0.0060%
06-30	Andrew Callos	Fiscal year	Executive/Senior Manager	45,000	54.53	1.64M	0.0362%
06-30	Sung Lee	Fiscal year	Chief Financial Officer	3,336	68.15	152K	0.0027%
06-28	Sung Lee	Fiscal year	Chief Financial Officer	9,402	65.42	410K	0.0076%
06-23	Sung Lee	Fiscal year	Chief Financial Officer	116,190	64.70	5.01M	0.0934%
06-22	Fady Malik	Fiscal year	Chief Technology Officer	10,500	43.66	306K	0.0084%
06-14	Robert Blum	Sell	Chief Executive Officer	-7,500	70.46	-	0.0060%
06-08	Fady Malik	Fiscal year	Chief Technology Officer	10,500	37.89	265K	0.0084%
05-31	B. Parshall	Sell	Director	-5,000	74.08	-	0.0040%
05-31	Edward Kaye	Sell	Director	-2,933	76.09	-	0.0024%
05-31	Andrew Callos	Fiscal year	Executive/Senior Manager	45,000	48.67	1.46M	0.0362%
05-26	B. Parshall	Free	Director	7,152	-	-	0.0058%
05-26	Robert Blum	Sell	Chief Executive Officer	-7,500	77.21	-	0.0061%
05-26	James Daly	Free	Director	7,152	-	-	0.0058%
05-26	Nancy Wysenski	Free	Director	7,152	-	-	0.0058%
05-26	Muna Bhanji	Free	Director	7,152	-	-	0.0058%
05-26	John Henderson	Free	Chairman	7,152	-	-	0.0058%
05-26	Edward Kaye	Free	Director	7,152	-	-	0.0058%
05-26	Robert Harrington	Free	Director	7,152	-	-	0.0058%
05-26	Wendell Wierenga	Free	Director	7,152	-	-	0.0058%
05-26	Robert Landry	Free	Director	7,152	-	-	0.0058%
05-18	Fady Malik	Fiscal year	Chief Technology Officer	10,500	41.74	292K	0.0085%
05-13	Robert Blum	Sell	Chief Executive Officer	-7,500	77.92	-	0.0061%
05-04	Wendell Wierenga	Fiscal year	Director	12,096	43.70	352K	0.0098%
05-04	Andrew Callos	Fiscal year	Executive/Senior Manager	33,999	58.19	1.32M	0.0276%
05-04	Sung Lee	Sell	Chief Financial Officer	-23,906	76.87	-	0.0194%
05-04	Fady Malik	Fiscal year	Chief Technology Officer	10,500	42.58	298K	0.0085%
05-04	John Henderson	Fiscal year	Chairman	60,000	41.79	1.67M	0.0487%
04-30	Andrew Callos	Fiscal year	Executive/Senior Manager	47,571	51.32	1.63M	0.0386%
04-28	Robert Blum	Sell	Chief Executive Officer	7,500	59.62	447K	0.0061%
04-20	Fady Malik	Fiscal year	Chief Technology Officer	10,500	36.74	257K	0.0085%
04-14	Edward Kaye	Free	Director	191	65.37	12.49K	0.0002%
04-14	James Daly	Free	Director	191	65.37	12.49K	0.0002%
04-14	Wendell Wierenga	Free	Director	95	65.37	6.21K	0.0001%
04-14	Robert Blum	Sell	Chief Executive Officer	7,500	65.38	490K	0.0061%
04-14	Nancy Wysenski	Free	Director	95	65.37	6.21K	0.0001%
04-14	John Henderson	Free	Chairman	325	65.37	21.25K	0.0003%
04-14	Andrew Callos	Sell	Executive/Senior Manager	7,449	66.02	492K	0.0060%
04-14	Robert Harrington	Free	Director	191	65.37	12.49K	0.0002%
04-06	Fady Malik	Fiscal year	Chief Technology Officer	13,500	36.76	331K	0.0110%
03-31	Robert Blum	Sell	Chief Executive Officer	7,500	66.63	500K	0.0061%
03-30	Andrew Callos	Sell	Executive/Senior Manager	3,639	65.00	237K	0.0030%
03-17	Andrew Callos	Sell	Executive/Senior Manager	1,930	62.07	120K	0.0016%
03-16	Andrew Callos	Sell	Executive/Senior Manager	8,542	62.15	531K	0.0070%
03-16	Fady Malik	Sell	Chief Technology Officer	12,033	62.15	748K	0.0098%
03-16	Robert Blum	Sell	Chief Executive Officer	36,601	62.15	2.27M	0.0299%
03-16	Sung Lee	Sell	Chief Financial Officer	4,935	62.15	307K	0.0040%
03-15	Andrew Callos	Sell	Executive/Senior Manager	1,709	61.03	104K	0.0014%
03-14	Jeffrey Hessekiel	Free	Chief Administrative Officer	51,791	-	-	0.0424%